Daily non-political popular news in brief.

1-year results of bronchial thermoplasty in refractory asthma

Data from the Research in Severe Asthma trial of bronchial thermoplasty published in the American Journal of Respiratory and Critical Care Medicine show that patients experienced long term improvement in pulmonary function, improved quality of life and asthma control, and a reduction in rescue medication use for patients treated with bronchial thermoplasty.

Read more »

Keywords: 1-year, results, bronchial, thermoplasty, refractory, asthma, year, result

« Previous | Next »

Similar news on "1-year results of bronchial thermoplasty in refractory asthma":

1. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
   05-21-2007 · EurekAlert!
   Final results of the first randomized and controlled clinical study of bronchial thermoplasty, the Asthma Intervention Research Trial, were reported today at the annual scientific assembly of the American Thoracic Society. This follows the March publication of the AIR Trial results in the New England Journal of Medicine. These results include patients treated with the outpatient procedure demonstrated a 50 percent decrease in asthma attacks and a 45 percent reduction in rescue medication use.
   Similar news · Read more »
   
2. Bronchial thermoplasty may allow severe asthma patients to wean off oral corticosteroids
   05-23-2007 · EurekAlert!
   Positive results from the Research in Severe Asthma (RISA) Trial of Bronchial Thermoplasty were reported today at the annual scientific assembly of the American Thoracic Society (ATS). Clinically and statistically significant improvements in pulmonary function, asthma control, and quality of life, as well as a reduction in use of rescue medications, were observed following the bronchial thermoplasty procedure in patients with severe asthma. Bronchial Thermoplasty is first non-drug treatment for asthma.
   Similar news · Read more »
   
3. Groundbreaking Canadian asthma study
   03-28-2007 · EurekAlert!
   Study shows that patients treated with bronchial thermoplasty, the first non-drug treatment for asthma, demonstrated an overall improvement in asthma control.
   Similar news · Read more »
   
4. ECP may be effective in treating Crohn's disease
   05-25-2007 · EurekAlert!
   Results from an international multi-center Phase II clinical trial suggest that extracorporeal photopheresis (ECP) may be effective in treating patients with clinically active (OR symptomatic) Crohn's disease who cannot tolerate or are refractory to immunosuppressants and/or anti-TNF agents.
   Similar news · Read more »
   
5. Stem cell transplantation procedure results in long-term survival for amyloidosis patients
   08-07-2007 · EurekAlert!
   Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center have found that high-dose chemotherapy and blood stem cell transplantation can result in long-term survival for patients diagnosed with primary systemic light chain Amyloidosis.
   Similar news · Read more »
   
6. Breastfeeding does not protect children against developing asthma or allergies
   09-11-2007 · EurekAlert!
   Breastfeeding exclusively or for a prolonged period does not protect children against developing asthma and allergies, according to the results of a large randomized trial published online today.
   Similar news · Read more »
   
7. A PIN(1) prick for lung scarring: inhibiting PIN1 reduces rodent lung scarring
   01-10-2008 · EurekAlert!
   Chronic asthma often results in scarring of the lung airways (airway fibrosis) and this can cause airway obstruction. The soluble factor TGF-beta-1, produced by inflammatory cells known as eosinophils, drives the processes that cause airway fibrosis. New data, generated in rodents, has now led to the suggestion that targeting the protein PIN1 might provide a new approach to limiting airway fibrosis driven by the production of TGF-beta-1 by activated eosinophils in individuals with chronic asthma.
   Similar news · Read more »
   
8. Asthma linked to soot from diesel trucks in Bronx
   10-16-2006 · EurekAlert!
   Soot particles spewing from the exhaust of diesel trucks constitute a major contributor to the alarmingly high rates of asthma symptoms among school-aged children in the South Bronx, according to the results of a five-year study by researchers at New York University's School of Medicine and Robert F. Wagner Graduate School of Public Service.
   Similar news · Read more »
   
9. Preliminary results suggest Certolizumab Pegol is effective in reducing signs and symptoms
   06-14-2007 · EurekAlert!
   Fifty-nine percent of patients receiving certolizumab pegol 200mg plus methotrexate, and 61 percent of patients receiving certolizumab pegol 400mg plus methotrexate every two weeks achieved a 20 percent improvement in symptoms (known as an American College of Rheumatology 20 Response) after 24 weeks' treatment, according to a study presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. Only 14 percent of patients receiving methotrexate alone achieved an ACR20 response over the same period, highlighting the superiority of the treatment combination at both doses of certolizumab pegol in patients refractory to methotrexate.
   Similar news · Read more »
   
10. Reactions to 'false-positive' prostate cancer screenings assessed
    03-02-2007 · EurekAlert!
    Men who get a "false-positive" prostate cancer result -- an abnormal screening test followed by a biopsy indicating no evidence of cancer -- appear more likely to worry about their subsequent risk of cancer and report more problems with sexual function compared to men with normal screening results.
    Similar news · Read more »